Amiodarone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter
Condition:   Atrial Fibrillation Paroxysmal Interventions:   Drug: Pharmacological cardioversion with Amiodarone;   Drug: Pharmacological cardioversion with Refralon Sponsor:   National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2022 Category: Research Source Type: clinical trials